Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 10, 2010 - Issue 11
Submit an article Journal homepage
390
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

Michael R Shurin University of Pittsburgh Medical Center, Departments of Pathology and Immunology, Pittsburgh, PA, USA
,
Melissa Gregory National Cancer Institute at Frederick, Applied and Developmental Research Support Program, SAIC-Frederick, Inc., Building 560 Room 12-79, Frederick, MD 21702, USA +1 301/846 1890; +1 301/8246 6757; [email protected]
,
John C Morris National Cancer Institute, Center for Cancer Research, Metabolism Branch, Bethesda, MD, USA
&
Anatoli M Malyguine National Cancer Institute at Frederick, Applied and Developmental Research Support Program, SAIC-Frederick, Inc., Building 560 Room 12-79, Frederick, MD 21702, USA +1 301/846 1890; +1 301/8246 6757; [email protected]
Pages 1539-1553 | Published online: 19 Oct 2010

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Teilo H. Schaller & John H. Sampson. (2017) Advances and challenges: dendritic cell vaccination strategies for glioblastoma. Expert Review of Vaccines 16:1, pages 27-36.
Read now
Jianting Long, Bo Zhou, Heping Li, Qiangsheng Dai, Bing Zhang, Sizhong Xing, Zhirong Zeng, Wei Chen & Jianyong Yang. (2013) Improvement of HBsAg Gene-Modified Dendritic Cell-Based Vaccine Efficacy by Optimizing Immunization Method or the Application of β-glucosylceramide. Immunological Investigations 42:2, pages 137-155.
Read now
Byram W Bridle. (2011) Neuroendocrine cancer vaccines in clinical trials. Expert Review of Vaccines 10:6, pages 811-823.
Read now

Articles from other publishers (16)

Xiaoyi Hu, Weilin Zhou, Ruyu Pi, Xia Zhao & Wei Wang. (2022) Genetically modified cancer vaccines: Current status and future prospects. Medicinal Research Reviews 42:4, pages 1492-1517.
Crossref
Inez Wens, Ibo Janssens, Judith Derdelinckx, Megha Meena, Barbara Willekens & Nathalie Cools. (2021) Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies. International Journal of Molecular Sciences 22:14, pages 7536.
Crossref
Haiyan Zhang, Yongfei Xie, Zhi Hu, Hong Yu, Xiang Xie, Yingchun Ye, Wenfeng Xu, Siji Nian & Qing Yuan. (2021) Integrative Analysis of the Expression of SIGLEC Family Members in Lung Adenocarcinoma via Data Mining. Frontiers in Oncology 11.
Crossref
Angelique Sao-Mai Sy Do, Takayuki Amano, Lincoln A. Edwards, Lei Zhang, Mariza De Peralta-Venturina & John S. Yu. (2020) CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model. Molecular Therapy - Oncolytics 18, pages 295-303.
Crossref
Kui Wang, Forrest M. Kievit & Miqin Zhang. (2016) Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies. Pharmacological Research 114, pages 56-66.
Crossref
Remi J. Creusot, Manuela Battaglia, Maria-Grazia Roncarolo & C. Garrison Fathman. (2016) Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes. Stem Cells 34:4, pages 809-819.
Crossref
E. Yu. Rybalkina, G. V. Pavlova & A. A. Stavrovskaya. (2015) Recent news in the glioblastoma research. Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 9:1, pages 1-12.
Crossref
Leon P. Bignold. 2015. Principles of Tumors. Principles of Tumors 309 338 .
Olivier Gasser & Ian F. Hermans. 2015. Subunit Vaccine Delivery. Subunit Vaccine Delivery 243 257 .
B R Anderson, K Karikó & D Weissman. (2012) Nucleofection induces transient eIF2α phosphorylation by GCN2 and PERK. Gene Therapy 20:2, pages 136-142.
Crossref
Anatoli Malyguine, Kimberly Dunham, Thomas J. Sayers & Michael R. Shurin. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment 695 706 .
Anatoli Malyguine, Viktor Umansky & Michael R. Shurin. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment 1 12 .
Eva LionEvelien L.J.M. Smits, Zwi N. Berneman & Viggo F.I. Van Tendeloo. (2012) NK Cells: Key to Success of DC-Based Cancer Vaccines?. The Oncologist 17:10, pages 1256-1270.
Crossref
Anatoli M. Malyguine, Susan L. Strobl & Michael R. Shurin. (2011) Immunological monitoring of the tumor immunoenvironment for clinical trials. Cancer Immunology, Immunotherapy 61:2, pages 239-247.
Crossref
Ilse Van Brussel, Zwi N. Berneman & Nathalie Cools. (2012) Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System. Mediators of Inflammation 2012, pages 1-14.
Crossref
Katherine Kabaker, Kathryn Shell & Howard L. Kaufman. (2011) Vaccines for Colorectal Cancer and Renal Cell Carcinoma. The Cancer Journal 17:5, pages 283-293.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.